Skip to content

Informational Tool for Smoking Cessation in COPD Patients

Implementation and Impact Study of an Informational Tool for Smoking Cessation in COPD Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06872450
Acronym
IMPACT-BPCO
Enrollment
15
Registered
2025-03-12
Start date
2025-02-14
Completion date
2025-05-09
Last updated
2025-08-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Keywords

informational and motivational tool

Brief summary

Chronic obstructive pulmonary disease (COPD) is a lung disease that affects nearly 8% of the adult population and causes 18,000 deaths per year in France. The most frequent cause of this pathology is smoking. COPD patients who stop smoking have a better quality of life, a marked a significant slowdown in disease progression and an increased life expectancy. Investigators propose to carry out a quantitative study among patients smokers suffering from COPD, by setting up a tool in the form of an motivational intervention specific to this population.

Detailed description

implementing a tool in the form of an informational intervention with a specific motivational intervention

Interventions

OTHERinformational intervention

informational intervention

Sponsors

Hopital Nord Franche-Comte
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* People suffering from chronic obstructive pulmonary disease (COPD) stage 2/3 * People treated at HNFC * Smokers

Exclusion criteria

* People with cognitive disorders compromising comprehension and completion of the study

Design outcomes

Primary

MeasureTime frameDescription
motivational effectiveness60 daysMotivation to stop smoking (QMAT test)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026